![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 4
2022
Yuan, Feng; Wang, Yingshuai und Ma, Chiyuan
(2022):
Current WHO Guidelines and the Critical Role of Genetic Parameters in the Classification of Glioma: Opportunities for Immunotherapy.
In: Current Treatment Options in Oncology, Bd. 23, Nr. 2: S. 188-198
Yuan, Feng; Cong, Zixiang; Cai, Xiangming; Zhu, Junhao; Yuan, Lei; Wang, Yingshuai; Tang, Chao und Ma, Chiyuan
(2022):
BACH1 as a potential target for immunotherapy in glioblastomas.
In: International Immunopharmacology, Bd. 103, 108451
Yuan, Feng; Cai, Xiangming; Cong, Zixiang; Wang, Yingshuai; Geng, Yuanming; Aili, Yiliyaer; Du, Chaonan; Zhu, Junhao; Yang, Jin; Tang, Chao; Zhang, Aifeng; Zhao, Sheng und Ma, Chiyuan
(2022):
Roles of the m(6)A Modification of RNA in the Glioblastoma Microenvironment as Revealed by Single-Cell Analyses.
In: Frontiers in Immunology, Bd. 13, 798583
2021
Yuan, Feng; Cai, Xiangming; Zhu, Junhao; Yuan, Lei; Wang, Yingshuai; Tang, Chao; Cong, Zixiang und Ma, Chiyuan
(13. Dezember 2021):
A Novel Immune Classification for Predicting Immunotherapy Responsiveness in Patients With Adamantinomatous Craniopharyngioma.
In: Frontiers in Neurology, Bd. 12, 704130
[PDF, 6MB]